目的 探讨微创血肿淬吸术和开颅血肿清除术治疗高血压脑出血的临床疗效的差异.方法 回顾性分析2004年1月至2010年6月行微创血肿淬吸术或开颅血肿清除术治疗高血压脑出血共256例患者的临床资料.结果 巨大量血肿组行微创血肿淬吸术疗效为优、良的百分率[3(7.3%)、7(17.1%)]低于开颅血肿清除术[11(23.4%)、18(38.3%)],差异有统计学意义(P<0.05).结论中等量血肿患者(30～60 mL)选择微创血肿淬吸术或开颅血肿清除术均可,巨大量血肿患者(>60～90 mL)以选择开颅血肿清除术为佳.%Objective To evaluate the effective difference between micro-invasive hematoma aspiration and craniotomy in treating hypertensive cerebral hemorrhage. Methods The clinical data in 256 cases of hypertensive cerebral hemorrhage treated by micro-invasive hematoma aspiration and craniotomy in our hospital from January 2004 to June 2010 were retrospectively analyzed. Results In the massive hemorrhage group,the excellent rate and the effective rate of the micro-invasive surgery were 7. 3% (3 cases) and 17. 1% (7 cases)respectively, which were lower than 23. 4 % (11 cases)and 38. 3% (18 cases)of craniotomy(P<0. 05). Conclusion In hypertensive cerebral hemorrhage,moderate amount of hematoma with 30 - 60 mL is indicative to micro-invasive hematoma aspiration or craniotomy,however,massive hematoma with 60 - 90 mL should select craniotomy.
展开▼
